Skip to Main Content

Paper Details

A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.
mBio
3
2023
-1 Envs, Chimpanzee SIV, Chimpanzee SIV Envelope Glycoprotein, Env, Envs, HIV, HIV-, HIV-1, HIV-1 Env trimers, RMs, SCIV, SCIVs, SIV, SIVcpz, V2, V2-apex, V2-apex bNAb, V2-apex bNAb heavy-chain precursor, V2-apex bNAb precursor-expressing mouse B cells, bNAb, bNAbs, chimpanzee SIV, chimpanzee SIV (SIVcpz) Env, cross, cross-reactive lineages, envelope glycoprotein, germ, heavy, human, human V2-apex bNAb precursors, mice, mouse, precursor B cells, primate, rhesus macaques, simian-chimpanzee immunodeficiency viruses, trimer, wild-type SIVcpz Envs
Author NameAffiliation
Frederic Bibollet-RucheUniversity of Pennsylvania
Frederic Bibollet-RucheUniversity of Pennsylvania
Yingying LiUniversity of Pennsylvania
Yingying LiUniversity of Pennsylvania
Ashwin N SkellyUniversity of Pennsylvania
Ashwin N SkellyThe Wistar Institute
Ashwin N SkellyUniversity of Pennsylvania
Elena E GiorgiLos Alamos National Laboratory
David C MontefioriDuke University School of Medicine
Kevin WieheDuke Human Vaccine Institute, Duke University School of Medicine
Kevin WieheDuke University School of Medicine
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bette KorberLos Alamos National Laboratory
Barton F HaynesDuke Human Vaccine Institute, Duke University School of Medicine
Barton F HaynesDuke University School of Medicine
George M ShawUniversity of Pennsylvania
George M ShawUniversity of Pennsylvania
Beatrice H HahnUniversity of Pennsylvania
Beatrice H HahnUniversity of Pennsylvania
  • 1 - 19

Datasets

Release 1.2